Molecular analyses of metallothionein gene regulation
It uses the GLP-1/GIP dual incretin backbone (the same MAR709 chassis behind tirzepatide) instead of GLP-1 alone, which expands the targeted-cell population to include cells that express GIPR (most importantly, mature adipocytes)
Pharmacies must balance supply across patients using these drugs for diabetes and those using them for weight loss, often under conditions where availability, while improved compared to earlier shortages, is still uneven at the local level
The good news is that adaptation at higher doses typically happens faster than the initial adjustment
We use a phased 4R approach: Remove (antifungals and dietary change), Replace (digestive enzymes, HCl), Reinoculate (probiotics), and Repair (gut lining nutrients)